NUVIGIL

This brand name is authorized in United States. It is also authorized in Australia, Brazil, Israel, Turkey.

Active ingredients

The drug NUVIGIL contains one active pharmaceutical ingredient (API):

1	Armodafinil UNII V63XWA605I - ARMODAFINIL
	Armodafinil is an indirect dopamine receptor agonist; both armodafinil and modafinil bind in vitro to the dopamine transporter and inhibit dopamine reuptake. Armodafinil (R-modafinil) has pharmacological properties similar to those of modafinil (a mixture of R- and S-modafinil), to the extent tested in animal and in vitro studies.
	Read more about Armodafinil

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NUVIGIL Tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06BA13		N Nervous system → N06 Psychoanaleptics → N06B Psychostimulants, agents used for ADHD and nootropics → N06BA Centrally acting sympathomimetics
Discover more medicines within N06BA13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10912H, 10919Q, 10922W
BR	Câmara de Regulação do Mercado de Medicamentos	537521030009807, 537521030009907
IL	מִשְׂרַד הַבְּרִיאוּת	7833, 7880
TR	İlaç ve Tıbbi Cihaz Kurumu	8699638014026, 8699638014033, 8699638014132
US	FDA, National Drug Code	63459-205, 63459-215, 63459-220, 63459-225